Status:
COMPLETED
PENG Block Versus LP Block for THA Postop Pain
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Pain, Postoperative
Hip Pain Chronic
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The purpose of this randomized, double blinded, prospective study is to compare the postoperative analgesia provided by the PENG block to that provided by the LPB for patients undergoing primary anter...
Detailed Description
Regional anesthesia procedures represent a common modality for postoperative analgesia after total hip arthroplasty surgeries (THA). The standard practice many years has been the Lumbar Plexus block (...
Eligibility Criteria
Inclusion
- elective primary total hip arthroplasty surgery anterior approach
- provided informed consent
- no contraindications to medications used in providing the analgesic blocks
Exclusion
- contraindications to regional anesthesia, such as an allergy to amide local anesthetics
- pre-existing coagulopathy or thrombocytopenia \<100,000
- refusal of analgesic block for pain management
- presence of an progressive lower extremity neurological deficit
- localized or systemic infection
- chronic use of high dose opioid analgesics (defined as daily use greater than 60 mg oxycodone equivalents)
- pregnant
- refusal of consent
Key Trial Info
Start Date :
June 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2023
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT05261009
Start Date
June 13 2022
End Date
July 20 2023
Last Update
May 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Health Sciences
Winston-Salem, North Carolina, United States, 27157